07Dec
Private Equity Dealmakers Guidebook to Healthcare M&A During the Covid-19 Pandemic
The COVID-19 pandemic has stressed the M&A market at every stage of the deal-making process – from complicating on-site visits and intensifying the diligence process to introducing valuation gaps (relative to pre-COVID-19 expectations), complicating purchase agreement negotiations and limiting the availability of debt financing. Despite these hurdles, healthcare dealmakers have continued to pursue attractive acquisition opportunities throughout 2020, with the healthcare M&A market substantially...
By:
Bass, Berry & Sims PLC
Related
We’ve commented many times before that relatively few collective actions survive the “second stage...
Read More >
With the effective date of the CCPA quickly approaching, industry backed bills have been heavily deb...
Read More >
On August 14, 2019, the National Labor Relations Board (the “Board”) held that employers may requi...
Read More >
During a merger or an acquisition, businesses have a lot to focus on. Amid negotiations, regulatory ...
Read More >
Last Wednesday, a unanimous U.S. Supreme Court concluded that receipt of participant disclosures and...
Read More >
SMALL BUSINESS PROGRAMS & ADVISORY SERVICES - GAO Defers to SBA on When Runway Extension Act Appli...
Read More >